Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-23-004888

Chief Financial Officer acquired 242,508 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Francisco David Chief Financial Officer 2023-02-22 Grant or award +242,508 291,929 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Francisco David Chief Financial Officer 2023-02-22 Grant or award · Stock Option (Right to Buy) +287,892 287,892 D: show line 2 in the form
Loading xslF345X03/form4.xml…